
"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
The usual treatment for ovarian cancer is chemotherapy. Having no signs of cancer afterwards, means that there has been a complete response to chemotherapy.
After treatment, women have blood tests to look for a marker called CA125. Having an increased amount of CA125 in the blood may mean that the cancer has come back. But the test isn’t completely reliable. You can have an increased level of CA125, without any other signs or symptoms of the cancer having come back.
Doctors aren’t sure if women should have more treatment if this happens and what the best treatment is. Some women might have a called tamoxifen to delay having more chemotherapy. But this isn’t a
.
In this trial, researchers looked at a drug called epacadostat (INCB024360). It is a type of targeted drug called an immunotherapy. It helps the body’s attack cancer cells. Doctors thought it might keep the cancer under control for longer. But they weren’t sure so wanted to find out more.
Some women had tamoxifen and some had epacadostat. The trial compared these 2 drugs to see if epacadostat worked better than tamoxifen.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Kristeleit
Incyte Corporation
Freephone 0808 800 4040
"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”